{
  "name" : "dacemirror.sci-hub.se_journal-article_bf139bfeb7df49c024ff86ad17d4dacf_nethi2019.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Recent advances in inorganic nanomaterials for wound-healing applications",
    "authors" : [ "Susheel Kumar Nethi", "Chitta Ranjan Patra" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "Biomaterials Science\nREVIEW\nCite this: Biomater. Sci., 2019, 7, 2652\nReceived 17th March 2019, Accepted 24th April 2019\nDOI: 10.1039/c9bm00423h\nrsc.li/biomaterials-science\nRecent advances in inorganic nanomaterials for wound-healing applications\nSusheel Kumar Nethi, *a,b Sourav Das, b,c Chitta Ranjan Patra *b,c and Sudip Mukherjee *d\nChronic wounds have emerged as a major cause of mortality, especially in patients with diabetes and\nother pathologies. Statistics indicate that chronic wounds affect around 6.5 million patients annually, with\nwound care and management incurring huge economic costs. Growing incidence of chronic wounds\nand associated pathologies along with the limitations of current therapies have established a strong need\nfor novel and innovative approaches to accelerate wound healing. Conventionally, chronic wounds are\naddressed using various FDA-approved silver-based formulations and other biomaterials. However, the\ntoxicity associated with these conventional approaches, along with the increased frequency of chronic\nwound cases, makes the development of alternative therapies for effective wound healing necessary.\nRecently, researchers have investigated the design and development of nanoparticles, especially inorganic\nmetal nanoparticles, as promising candidates for addressing various pathological conditions, including\nwound healing. Several research groups, including ours, have designed numerous metal nanoparticles\n(including silver, gold, zinc oxide, cerium oxide, terbium hydroxide, silica, titanium oxide, copper) and\ndemonstrated their wound-healing properties using in vitro and in vivo models. The rise of nanotechno-\nlogy-based platforms in wound healing is evidenced by the tremendous impact and number of publi-\ncations observed in recent years, which has emphasized the robust potential of inorganic nanomedicine\nfor addressing wounds. Therefore, the importance of these inorganic nanomaterial-based interventions\nfor wound-healing applications needs to be emphasized to inform and encourage scientists and young\nresearchers globally to engage with this expanding area of biology and medicine. In this review article, we\nmainly focus on highlighting the role of inorganic nanomaterials and nanomaterial-based approaches for\nwound healing and tissue regeneration, along with their mechanistic properties, clinical status, challenges,\nand future directions."
    }, {
      "heading" : "1. Introduction",
      "text" : "Wounds are generally considered to be sharp injuries to the skin tissue where the dermal layers are cut, punctured, or torn due to external stimuli or trauma. Depending on their position and exposure, wounds are classified as open or closed. In dayto-day life, wounds are a challenging clinical problem associated with various complications leading to frequent morbidity and mortality.1 Chronic wounds have emerged as a substantial\nissue, especially for patients with diabetes, and significantly affect healthcare costs. Wounds are generally classified into two types according to their healing period. Wounds that heal themselves in a predictable time frame followed by anatomical and functional tissue restoration are known as acute wounds.2 These wounds are commonly acquired through traumatic tissue loss or surgical procedures.3,4 In contrast, wounds that do not heal over a predictable period of time, leading to further complications, such as infection and difficulty healing, are known as chronic wounds.5 Diabetic ulcers, vascular ulcers, and pressure ulcers are considered chronic wounds. Diabetes is a major risk factor for chronic wounds, along with age, peripheral artery diseases, immuno-compromised conditions, and peripheral neuropathy. In the lifetime of a diabetic patient, the chance of developing a foot ulcer is estimated to be 25%, leading to dreadful consequences such as severe infection and limb amputation.5\nIn the United States alone, an estimated 6.5 million patients are affected with chronic wounds and around US$25 billion are\naDepartment of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA. E-mail: susheel.nethi@gmail.com bDepartment of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, Telangana State, India. E-mail: crpatra@iict.res.in cAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad- 201002, India dDepartment of Bioengineering, Rice University, Houston, TX 77030, USA. E-mail: sudip.mukherjee1988@gmail.com\n2652 | Biomater. Sci., 2019, 7, 2652–2674 This journal is © The Royal Society of Chemistry 2019\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\nView Article Online View Journal | View Issue\nspent annually by the medical system on chronic wound management.6–8 The market for wound-care products has massively expanded to more than US$15 billion, along with US$12 billion for handling wound scars.9,10 Surprisingly, a cost of around US$9 billion is imposed on healthcare providers and patients annually in the US to perform lower limb amputations resulting from diabetic foot ulcers.11 Furthermore, the aging population is at increased risk of the socioeconomic and medical burdens caused by wound complications. These high health and socioeconomic burdens highlight the need for rigorous investigation to develop novel therapeutics in this field.\nLong-term studies have demonstrated that this condition is observed in majority of the diabetic patients, leading to 80% mortality post-amputation.12,13 Therefore, researchers globally are making rigorous efforts to develop clinically feasible novel therapeutic approaches for controlling infections and accelerating the wound healing process. In the past few decades, researchers have attempted to address chronic wound healing using several drug and biomaterials-based approaches, few of which have been approved by the FDA and in clinical phase trials. The growing incidence of conditions associated with chronic wounds and the limitations of existing methods demonstrate the urgent need for the development of novel platforms for overcoming unmet medical challenges associated with wound care management.14\nIn this context, nanotechnology has introduced excellent and novel advances in the treatment and diagnosis of various diseases, and nanomedicine approaches have boosted healthcare management.15 Various nanomaterials have been explored for controlling microbial infections and accelerating wound healing.16–18 Nanotechnology has impacted various fields of biomedical engineering, such as tissue engineering, regenerative medicine, gene/protein/drug delivery, and bioimaging, owing to the unique physicochemical and biological properties of nanoscale materials.19–23 Nanotechnology and nanobased approaches have emerged as potential platforms for wound healing applications, as evidenced by the numerous publications in this field.24 Several polymeric, lipid-based, ceramic, inorganic, metal, and metal oxide nanomaterials have been widely investigated for cutaneous wound healing.25–27 Recently, researchers have initiated the design and development of inorganic metal nanoparticles as promising candidates for various biological problems, especially wound healing. Several research groups, including ours, have prepared various metal nanoparticles, such as silver,28 gold,29 zinc oxide,30 cerium oxide,31 terbium hydroxide,32 titanium oxide,33 and copper,34 and demonstrated their excellent wound healing properties using in vitro and in vivo models. These rigorous investigations by global nanomedicine researchers have stressed the impact of inorganic nanomaterials in wound healing applications. The present review focuses on briefly describing the types, causes, physiological mechanisms, and pathology of wound healing. The role of novel inorganic nanomaterials in wound healing and tissue regeneration, and their mechanisms, advantages and disadvantages, clinical status, and future directions are highlighted."
    }, {
      "heading" : "2. Wound healing: types and causes",
      "text" : "Wounds are complex biological processes that comprise a series of overlapping phases.35 There are two main types of wound, namely, acute and chronic, depending on the healing time and contamination level.14 Acute wounds have fewer complications, while chronic wounds take longer to heal. Other types of wound (clean, contaminated, infected, and colonized) can result from accidental injury, pathogenic infections, and other causes. Burns, heat, and cuts are the common causes of wounds, and result in further complications. Similarly, wounds can be differentiated as open (cutaneous) or closed (non-cutaneous). Open wounds, which are exposed to environment, can be subcategorized as incisions, abrasions, and lacerations. Incisions are surgical cuts made by sharp objects, and can be shallow or deep. Abrasion is a superficial injury caused by frictional force,36 and can be further divided into three subtypes, namely, grazes (due to mechanical force), scratches (due to cuts by sharp objects), and pressure abrasions. Lacerations are caused by overstretching of the soft tissue,37 with causes including splitting, blunt trauma, and tearing of the soft tissue resulting from accidental or homicidal incidents. Crushing of the skin between blunt objects results in splitting. Other wounds, such as stab and gunshot wounds, are also classified as open wounds.36 Piercing or penetration of the skin by pointed objects, such as nails, metallic instruments, and knifes, result in stab wounds.38 Similarly, gunshot wounds are caused by being hit with a bullet projectile.\nIn contrast, closed wounds arise inside the body, and can be further subdivided into hematomas, bruises, contusions and concussion, and crushing injuries, among others. Generally, hematomas are caused by the accumulation of blood outside the blood vessels, ultimately becoming bruises.39 A bruise is an internal injury caused by mechanical force, and can be observed on the outside of the body (superficial) or deep inside the body.40 Blood vessel rupture causes blood to exit the vessels, and red blood cell (RBC) lyses are observed. Contusions and concussion occur simultaneously as a result of blood accumulation under the skin and damage to the brain tissue.41,42 Crushing injuries occur when a large force is applied over a longer period of time.\nThere are also other types of wound, such as thermal wounds, chemical wounds, and electrical wounds. Thermal wounds are caused by extreme cold and hot temperatures,43 while chemical wounds are caused by contact with or inhalation of chemical substances, resulting in damage to lungs and other body parts. Electrical wounds are caused by electrical current passing through the body.44"
    }, {
      "heading" : "3. Physiology and signaling mechanisms in wound healing process: role of angiogenesis",
      "text" : "Wound healing is a natural physiological process that occurs in response to any tissue injury or damage. This dynamic\nThis journal is © The Royal Society of Chemistry 2019 Biomater. Sci., 2019, 7, 2652–2674 | 2653\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\nphenomenon involves intricate interactions between various cell types, coagulation factors, connective tissue, growth factors, cytokines, and the vascular system. There are four stages in the wound healing process (Fig. 1),18,35 which are described briefly in the following sections:\n(i) Hemostasis phase\nTrauma to the skin tissue that causes blood loss will first result in constriction of the blood vessels to stop bleeding (hemostasis). Clotting will be initiated due to platelet aggregation, followed by a series of coagulation steps.45 The wound is first sealed with a fibrin mesh, which later hardens to become a scab. At the repair site, a matrix will be formed for the invasive cells.3 The release of pro-coagulants, such as pro-thrombin, aids the formation of clots or thrombus, which retains the blood cells and platelets at the wound site.\n(ii) Inflammatory phase\nThe next phase in the wound healing process is inflammation initiated by the release of inflammatory mediators (prostaglan-\ndins and histamine), which increase the permeability and vasodilation of the surrounding vessel. Neutrophils migrate to the injured site to kill invading microbes through phagocytosis.3 Immune cells, such as mastocytes, Langerhans cells, and gamma-delta cells, become activated and secrete cytokines and chemokines.35 Macrophages actively engage in apoptotic cell removal, host defense mechanisms, and injured tissue rehabilitation.46 Mast cells and leukocytes also help wound healing progress to further stages.47,48 Redness, heat, pain, and swelling are observed in this phase owing to the inflammatory response.\n(iii) Proliferative phase\nInflammation is followed by the proliferative phase, where the wound area is built with new connective tissue consisting of collagen and extracellular matrix (ECM). Myofibroblasts assemble around the wound rim and pull the edges through contraction, which significantly promotes wound healing.49 The granulation process forms a new wound matrix, with a ground substance providing a scaffold-like structure for the growth of new\nFig. 1 Phases of cutaneous wound healing depicting cells and molecules responsible for the regaining of a healthy barrier. Reproduced from ref. 18 S. Hamdan, I. Pastar, S. Drakulich, E. Dikici, M. Tomic-Canic, S. Deo and S. Daunert, ACS Central Science, 2017, 3, 163–175. Copyright © 2017 American Chemical Society (Open access).\n2654 | Biomater. Sci., 2019, 7, 2652–2674 This journal is © The Royal Society of Chemistry 2019\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\nblood capillaries and connective tissue. Macrophages recruited at the wound site produce several growth factors, such as transforming growth factor (TGF) and tumor necrosis factor (TNF), which promote the angiogenesis, extracellular matrix, and growth of new tissue.50,51 A pinky red color signals healthy granulation tissue and promoted wound healing, while darkcolored granulation tissue indicates an infected or ischemic wound.52 The final stage of the proliferation phase is re-epithelialization, in which the growth and migration of epithelial cells occurs across the wound. This process is accelerated by a moist wound environment.53,54\n(iv) Maturation phase\nThe final phase of wound healing, also known as the remodeling stage, is maturation. Maturation begins at around the third week after wound formation and can last for several months or a year, depending on the complexity of the wound. The recovery of normal structural organization and increased tensile strength are the main aims of this remodeling stage. Most\nblood capillaries, macrophages, and fibroblasts disappear from the wound region, either through apoptosis or unknown mechanisms. Remodeling of the granulation tissue occurs, leading to the formation of scar tissue55 with a reduced number of cells and an increased level of collagen fibres.35 The degradation of type-III collagen and an increase in type-I collagen and wound closure are observed in this maturation phase.56 Altogether, all phases involved in wound healing are complex and failure to progress through the phases can lead to chronic wounds."
    }, {
      "heading" : "4. Pathological conditions associated with wounds",
      "text" : "Wounds generally begin as minor traumatic injuries, but can extend without healing for long periods, leading to chronic conditions. There are several types of chronic wounds, such as diabetic ulcers, venous and arterial ulcers, pressure\nFig. 2 Clinical features of most common wound-healing pathologies. The repair response can be disturbed by a multitude of local and systemic factors, leading to diverse wound-healing pathologies. (A) Medial aspect of lower leg with venous leg ulcer (VLU). (B) Lateral aspect of lower leg with an arterial ulcer. (C) Diabetic foot ulcer (DFU). (D) Pressure sore. (E) Hypertrophic scar after thyroid surgery. (F) Keloid. Reproduced from ref. 14 S. A. Eming, P. Martin and M. Tomic-Canic, Science Translational Medicine, 2014, 6, 265sr266. Copyright © 2014 AAAS. Credit: F. Reinhold/University of Cologne.\nThis journal is © The Royal Society of Chemistry 2019 Biomater. Sci., 2019, 7, 2652–2674 | 2655\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\nulcers, keloids, hypertrophic scars, fibrosis, and pressure sores (Fig. 2). A wound becomes chronic when normal healing is impaired by certain features, including an excessive or prolonged inflammatory phase,57 the development of resistant microbial growth infections,58,59 and the impaired re-epithelialization and growth of blood capillaries, and reduced local concentration and bioavailability of growth factors.60\n(i) Factors affecting wound healing\nThe physiological response to tissue injury or trauma is a natural process resulting in timely healing to restore the normal anatomy and function of skin tissue. However, for chronic wounds, this process is deregulated by prolonging or stalling the events in any phase of wound healing. There are several factors that lead to impaired wound healing, such as diabetes, obesity, malnutrition, medication, and lifestyle habits, including excessive alcohol intake and smoking.61"
    }, {
      "heading" : "5. Conventional treatment strategies",
      "text" : "Skin tissue repair and regeneration are among the most complex biological processes in humans. To maintain healthy skin and hasten the wound healing process, various therapies have already been examined with promising results. Wounds can be treated using both conventional and modern therapies. Conventional therapies employing plant extracts, honey, maggots, propolis, and larvae are fascinating alternatives. These traditional medicines are commonly used worldwide, especially in Latin America, Asia, and Africa.62 For example, honey is a natural sugar that plays a pivotal role in re-epithelialization when applied to the wound area.63 Similarly, leech therapy, such as those using maggots or propolis, aid wound debridement. In contrast, different plant extracts, such as Aloe vera and Vinca rosea, also augment the skin regeneration process when applied to the wound area.64"
    }, {
      "heading" : "6. Current treatment strategies",
      "text" : "There are various modern approaches in addition to conventional therapies. Use of these modern approaches has advanced wound healing treatments.\n(i) Hyperbaric oxygen therapy\nHyperbaric oxygen therapy is among the most recent approaches to wound healing. It is generally used in clinical practice and is beneficial for recalcitrant or complicated ulcers. Hyperbaric oxygen therapy uses flows oxygen to the wound site and ultimately retards amputation.65 This process has been observed to help maintain oxygen pressure to transcutaneous limbs in the case of ischemic ulcers. However, some drawbacks are associated with this therapy, such as pneumothorax and oxygen toxicity to the CNS, which have limited its application.66\n(ii) Negative pressure wound therapy\nNegative pressure wound therapy is generally useful for treating post-operative wound complications, and has found applications in vascular surgery, orthopedics, and cardiothoracic surgery. Negative pressure wound therapy accelerates collagen synthesis, and increases the skin perfusion level and tensile strength. This process is useful for both acute and chronic wounds, and helps ameliorate angiogenesis. This process has been observed to remove interstitial fluids and bacterial infections at the wound site, and clear the lymph nodes.67,68\n(iii) Bioengineered cell construct\nRecently, bioengineered cell construct has become of paramount importance in the treatment of venous leg ulcers, which are a type of life-threatening chronic wound (nonhealing) with a high level of morbidity. A bioengineered bilayered living cells construct (BLCC), consisting of neonatal fibroblast and keratinocytes in a type-I matrix derived from human foreskin, accelerates wound healing and obtained FDA approval under the trade name Apligraf in 1998.69\n(iv) Dressing materials\nVarious wound dressing materials are available on the market. Using dressing materials containing polymers that mimic the physical and biological properties of the surrounding tissues (native) ultimately aids the healing process.62 Furthermore, custom-designed dressing materials soak the wound area in excess fluid and escalate the healing process.70\n(v) Vascular surgery\nSurgery is now quite a common intervention for non-healing chronic diseases, such as venous leg ulcers. The chances of ulcer re-occurrence are low after surgery, which supports the use of surgery.71"
    }, {
      "heading" : "7. Limitations of conventional treatment strategies",
      "text" : "In addition to various uses, these conventional therapies are all associated with various limitations, such as the initiation of allergic reactions, unknown mechanisms of action, risks of infection, rapid drying of the wound area, and batch-to-batch variation.72,73 Furthermore, various medicines have been studied for their effects on wound healing, such as glucocorticoid steroids, non-steroidal anti-inflammatory drugs, and chemotherapeutic drugs. For example, glucocorticoid drugs act as anti-inflammatory mediators, resulting in psychosis, peptic ulceration, hyperglycemia, and poor bone healing. Furthermore, non-steroidal anti-inflammatory drugs, such as ibuprofen, naproxen, rofecoxib, and celecoxib, that are commonly used for pain reduction significantly suppress the COX1 and COX2 level by inhibiting prostaglandin production. Similarly, various chemotherapeutic drugs, such as bevacizumab, lenvatinib, cabozan-\n2656 | Biomater. Sci., 2019, 7, 2652–2674 This journal is © The Royal Society of Chemistry 2019\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\ntinib, brivanib, refametinib, and everolimus, also inhibit the wound repair process by reducing cell movement to injury sites. These drugs also affect collagen production, hamper fibroblast formation, minimize oxygen flow to the wound site, and reduce immunity, which delay wound healing.74"
    }, {
      "heading" : "8. Nanotechnology in wound healing: an alternative approach",
      "text" : "Nanotechnology is a rapidly growing field of research that has been used to solve various biological problems, both therapeutic and diagnostic. Recently, nanotechnology has been extensively studied for the treatment of various diseases, such as cancer, cardiovascular diseases, and diabetes, including wound healing.75–77 The emergence of both acute and chronic wounds on an epidemic scale has led to the development of alternative approaches using nanotechnology.57 Therefore, new technologies that aim to promote the healing process are urgently needed. In the last few decades, numerous nanotechnologies have emerged, providing tremendous opportunities owing to their unique properties and ideal applications. These technologies can address the complexity and specificity of wounds. Accordingly, various nanotherapies have been explored to treat different stages of wound healing. According to reports, two types of approaches are generally used in wound healing: (i) nanomaterials act as drugs that are intrinsically used therapeutically in wound healing; and (ii) nanomaterials act as vehicles/carriers to deliver therapeutic agents for wound treatment.18 The first approach consists of metal, metal oxide, non-metal, and metalloid-based nanoparticles that are used at different stages of wound management. Nanoparticles of metals including silver, gold, copper, titanium, terbium, and zinc, nonmetals including graphene materials, and metalloids (silica), have been utilized. The second approach uses nanoparticles based on antibiotics, antioxidants, growth factors, nucleic acids, and small molecules (nitric oxide, thrombin) with therapeutic benefits. Recently, our group demonstrated the wound healing efficacy of terbium hydroxide nanoparticles in a murine model using the concept of therapeutic angiogenesis induced by the nanomaterial.32 Another study by our group demonstrated the anti-microbial\nand wound healing properties of silver nitroprusside complex.78 These findings show that nanoparticle-based therapies are beneficial alternative approaches to wound healing."
    }, {
      "heading" : "9. Synthesis of inorganic nanoparticles",
      "text" : "The design and development of inorganic nanomaterials is crucial considering their unique optical, electronic, colloidal, and magnetic properties.79 The synthesis of inorganic nanoparticles (INPs) with well-defined shapes and sizes are essential to conserve their physicochemical properties for desired applications. Considering their vast applications in biology and medicine, there is a growing demand for the development of eco-friendly, cheap, and stable INPs.80 Researchers have explored various kinds of approaches for the synthesis of INPs, such as physical, chemical, and biological methods, as summarized in Table 1 based on the conditions and resources employed. Different design and fabrication methods for INPs might be used depending upon their application. Nowadays, greener syntheses of INPs from various bioresources, which yield uniform, stable, and nontoxic nanoparticles, are widely used for biomedical applications.81 INPs prepared using various methods are commonly characterized by analytical tools, such as X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), scanning electron microscopy (SEM), dynamic light scattering (DLS), and thermogravimetric analysis (TGA)."
    }, {
      "heading" : "10. Inorganic nanoparticles and nanomaterial-based formulation for wound healing",
      "text" : "Nowadays, various types of nanoparticles, including metal-based, non-metal-based, and metalloid-based nanoparticles, and small molecule, antibiotic, and growth factor-based nanoparticles, have been used to heal wounds of different stages. Various approaches used to repair wounds are primarily categorized based on the nanomaterial that delivers the drug, antibiotic, or siRNA, among\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\nothers, while the latter approach is based on tissue engineering properties. Herein, we have described some of the inorganic nanomaterial-based approaches to wound treatment. Various INPs have been explored for wound healing applications, as shown in Fig. 3.\n(a) Silver nanoparticles (AgNPs)\nSilver nanoparticles have long been used in various biomedical applications owing to their anti-bacterial, anti-cancer, wound healing, anti-angiogenesis, biosensing properties.82–86 The use of silver-based compounds to treat ulcers has been reported since the 5th century BC, while the antimicrobial activity of silver was established in the 19th century. However, the introduction of antibiotics in 1940 reduced the use of silver salts in ulcer treatment. Various silver compounds, including silver nitrate and silver sulfadiazine, are widely used for the treatment of chronic wounds and tissue burn infections.87 Conversely, these compounds can show tissue toxicity at higher doses owing to nonspecific silver ions released into the tissue. Therefore, researchers have developed nanocrystalline silver or silver nanoparticles that are effective at a much lower concentrations, resulting in lower toxicity compared with conventional silver.88 Silver nanoparticle-embedded dressings, such as Acticoat, have demonstrated controllable sustained release of silver ions that help overcome the potential toxicity and inactivation of protein in wound tissues.89 Recent reports by Rigo et al. demonstrated the safety of Acticoat Flex 3 (silver nanoparticle-based wound dressing) using in vitro and in vivo analysis.90 Although the AgNPs might decrease the temporary mitochondrial function, they do not cause cell cytotoxicity. An\nin vivo clinical study on human patients showed no toxicity, as observed by the absence of necrosis or apoptosis in the healed area. Furthermore, 17 days post-application of the silver dressing, the wound area was healed and the skin structure (epidermis and dermis) was re-established, leading to the reinstatement of normal skin (Fig. 4). In another recent report by Chai et al., the authors demonstrated the use of AgNPs biosynthesized from Delonix elata leaf aqueous extract in wound healing after anorectal surgery in human patients.91 After daily treatment of the wound area, the authors observed significant wound contraction after 10 days, with a weak inflammatory response. On day 17, the wound was entirely closed, indicating that biosynthesized AgNPs achieved rapid wound epithelialization. These published reports summarize that silver NPs can be effectively used in various wound-healing and antimicrobial applications. However, using a metallic compound can have some side effects that require study before clinical consideration. Recent studies investigating the biosafety of silver have demonstrated that AgNPs can be used as a therapeutic agent with acceptable biocompatibility.92 Another recent report showed that oral administration of commercial AgNPs to 60 healthy human volunteers did not produce toxicity markers.93 Therefore, AgNPs are promising for wound healing applications and will be widely used in the near future.93\n(b) Gold nanoparticles (AuNPs)\nGold nanoparticles have long been used in various biomedical applications including drug delivery, gene delivery, photothermal effects, anti-cancer, angiogenesis, and biosensing applications.94,95 Gold nanoparticles have recently been used by various research groups for their wound-healing applications, including in antibiotic delivery, as a tissue adhesive, and laseractivated wound healing.18,74,96–98 Chitosan-based gold nanocomposite adhesives showed much higher tissue adhesive properties than chitosan alone.99 Gold nanoparticle-embedded collagen scaffolds demonstrated much better skin wound healing compared with pristine collagen scaffolds, commercially available MatriDerm (MedSkin Solutions), and collagen sponges in adult rats.100 Chen et al. obtained better antibacterial activity and subsequent wound healing using cyclic lipopeptide surfactin (SFT)-functionalized gold nanodots compared with free SFT in a rodent wound model.101 In an interesting report, the authors employed a laser-activated suture-less approach to tissue wound sealing using plasmonic AuNPs.102 The AuNPs emitted heat upon NIR light irradiation that increased the local temperature and helped the wound tissue to reconfigure and interdigitate. Gold NPs have inherent antioxidant and antibacterial properties that aid the wound healing process through inflammatory and hemostasis phases.103 Owing to their good biocompatibility and excellent multifunctionality, gold nanoparticles have emerged as promising candidates for wound healing applications.\n(c) Graphene oxides\nIn the last decade, graphene oxide (GO) has been widely exploited for its biological applications in drug delivery, imaging, and biosensors. The unique basal plane structure\nFig. 3 Schematic illustration of various inorganic nanoparticles employed for wound healing. TbNRs: Terbium nanorods; CNTs: carbon nanotubes; AgNPs: silver nanoparticles; SPIONs: superparamagnetic iron-oxide nanoparticles; AuNPs: gold nanoparticles; MSN: mesoporous silica nanoparticles.\n2658 | Biomater. Sci., 2019, 7, 2652–2674 This journal is © The Royal Society of Chemistry 2019\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\nand shape of GO makes it feasible for surface functionalization with drugs, biomolecules, or other nanocomposites. Recently, GO has been investigated globally by various researchers for its potential applications in wound healing. Thangavel et al. fabricated reduced graphene oxide (rGO)embedded isabgol nanocomposite scaffolds for diabetic wound treatment.104 These nanocomposite scaffolds were developed by preparing a uniform dispersion of rGO in isabgol solution and characterized using various physicochemical techniques. Fibroblasts cultured on these scaffolds exhibited cell attachment, improved proliferation, and increased viability at longer incubation time points. Further in vivo studies in Wistar rats demonstrated that these rGO-incorporated isabgol nanocomposite scaffolds induced faster wound healing in normal and diabetic rats compared with untreated and isabgol-treated rat groups. Faster re-epithelialization, a higher granulation tissue shrinkage temperature, increased collagen concentration, accelerated wound contraction, and increased angiogenesis were observed in skin sections isolated from rGO + isabgol scaffold-treated rats. These observations indicated the future opportunities for these nanocomposite scaffolds as effective and affordable wound dressing materials for clinical application. Furthermore, Shahmoradi et al. developed a hybrid graphene oxide/silver/silver/arginine (GO/Ag/Arg)-based\nFig. 4 Depth profiles of Ag concentration (ng mg−1) after seven days of treatment. In this pilot study, biopsies were obtained from the same patient. One biopsy for silver analysis was taken from the healed part of the wound (top) and one from the unhealed (bottom) tissue. Panoramic images of other duplicate samples were obtained by optical microscopy, and zoomed in areas of representative portions are also shown for comparison. Reproduced from ref. 73 C. Rigo, L. Ferroni, I. Tocco, M. Roman, I. Munivrana, C. Gardin, W. R. Cairns, V. Vindigni, B. Azzena, C. Barbante and B. Zavan, Int. J. Mol. Sci., 2013, 14, 4817–4840. Copyright © 2013 MDPI (Open access).\nThis journal is © The Royal Society of Chemistry 2019 Biomater. Sci., 2019, 7, 2652–2674 | 2659\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\nnanostructure to address wound healing using a combination of pro-angiogenic and antibacterial activities.105 These hybrid nanocomposites embedded in electrospun polycaprolactone (PCL) scaffolds exhibited profound antibacterial activity against E. coli and S. aureus bacterial species and biocompatibility towards mammalian fibroblast cells. In vivo studies demonstrated significant repair and regeneration of wounds in mice treated with the PCL-GO/Ag/Arg nanocomposite scaffolds after 12 days of treatment time. Histological analysis showed the formation of a thick epidermis layer on the wound surface in PCL-nanocomposite treated mice. Therefore, the GO/Ag/Arg nanocomposite scaffolds could be developed as a promising agents for synergistic wound healing through a combination of antibacterial and angiogenesis properties. Mitra et al. developed a 3D scaffold by functionalizing nano-GO (NGO) with type-I collagen using an advanced grafting process for tissue engineering purposes.106 Physicochemical parameters, such as the NGO size, extent of collagen functionalization, and the surface properties of collagen-functionalized NGO were determined using various analytical tools. Interestingly, the authors showed that the mechanical strength of CFNO was three-fold greater than that of native collagen. Furthermore, curcuminloaded CFNGO scaffolds exhibited antibacterial activity against Gram-positive and Gram-negative bacteria. In vivo wound healing evaluation in male albino rats showed the faster wound healing efficiency of CFNGO scaffolds loaded with curcumin compared with treatment with collagen alone. These observations promote the application of curcumin-loaded CFNGO as a promising candidate for efficient wound healing applications in the near future. Overall, graphene and carbonbased nanomaterials are promising for various biomedical applications owing to their various physicochemical properties, and will be extensively used for wound healing applications.\n(d) Terbium hydroxide nanoparticles (TbNPs)\nRecently, rare earth elements have emerged as excellent agents for several biomedical applications. Among these, angiogenesis (new blood vessel growth) is tremendously influenced by various lanthanides, demonstrating their future prospect applications against various conditions, including wound healing. In the last decade, our group has been working on the design and development of various inorganic lanthanide nanomaterials that demonstrate excellent pro-angiogenic properties. Recently, we reported the synthesis and characterization of terbium hydroxide nanorods (THNs), which demonstrated enhanced viability, proliferation, and migration of endothelial cells, the fundamental steps needed for angiogenesis.32 This was also supported by the formation of new blood vessels in chick embryos treated with THNs. Mechanistic studies in endothelial cells and a chick embryo model showed the NOX-mediated generation of intracellular reactive oxygen species (ROS) by THNs and subsequent formation of key angiogenesis signaling molecules, such as nitric oxide (NO) through the PI3K/Akt/MAPK cascade. In vivo wound healing studies in a punch biopsy mouse model showed accel-\nerated wound closure in mice treated with THN formulation compared with untreated and vehicle control groups. Furthermore, serum levels of IL-4, IL-6, TNF-α, and IFN-γ cytokines in BALB/c mice administered with THNs were similar to those in untreated mice, signifying their nonimmunogenic nature. In another interesting study, Zhao et al. conducted the high-throughput screening of a series of nanomaterials, showing that terbium hydroxide nanorods and nanospheres possessed significant pro-angiogenic properties mediated through redox signaling, as observed in vitro in zebra embryonic primary cells and in vivo in transgenic zebra fish models.107 Therefore, we believe that a thorough understanding of molecular signaling pathways underlying THN-induced pro-angiogenesis could be useful for optimizing these proangiogenic terbium nanoparticle-based systems for effective wound healing. Although terbium nanoparticles show tremendous potential for wound healing applications, detailed studies are required to test their potential toxicity and adverse effects prior to clinical translation.\n(e) Copper nanoparticles (CuNPs)\nAngiogenesis, a process in which new blood vessels are generated from preformed vasculature, is considered to play pivotal role in wound healing, and is among the cardinal events linked to the wound repair process.57 Angiogenesis acts as preparative phase in all phases of wound healing through the proliferation and migration of endothelial cells. Endothelial cells release various chemokines and cytokines, which adhere to the scar site. Accordingly, angiogenesis helps repair damaged capillaries, supplies oxygen and nutrients to the wound site, and assists in returning normoxia and facilitating fibroplasia.108 Various growth factors, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) are known to promote wound healing by inducing angiogenesis. Among various metals, copper plays a vital role in wound healing using angiogenesis, where it helps promote VEGF (growth factor) and upregulates the integrin expression. Furthermore, copper also assists in stabilizing extracellular matrix proteins, fibrinogen, and collagen formation, which, in turn, aids the wound healing process. For example, Tiwari et al. bio-synthesized copper nanoparticles using Pseudomonas aeruginosa for wound healing applications.109 The authors showed that the biocompatible nanoparticles exhibited enhanced wound healing efficacy in rats (excision model) compared with the native form of copper. Furthermore, Borkow et al. used copper oxide to prepare dressing materials that aided wound healing.110 The authors showed that copper induced the production of placental growth factor (PLGF), vascular endothelial growth factor (VEGF), and hypoxia-inducible factor-1 alpha (HIF-1α), which ultimately escalated the wound closure process in diabetic mice (genetically engineered). The group also monitored the underlying mechanism of healing using copper, and mentioned that copper ameliorates the HIF-1α protein in the macrophage, which increased the TGFβ, MMP-2, and ephrin A1 involved in wound healing. Altogether, the authors provided insight into the future application of\n2660 | Biomater. Sci., 2019, 7, 2652–2674 This journal is © The Royal Society of Chemistry 2019\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\ncopper-impregnated dressing materials in both the treatment of acute and chronic wounds to validate its efficacy. Similarly, Gopal et al. fabricated chitosan-based copper nanocomposites (CCNC) for wound-healing applications.111 The authors showed that the usage of biocompatible chitosan added extra advantages (antifungal and antibacterial) in nanocomposite formation. The authors investigated the underlying mechanism for enhanced wound closure properties in the rat model, finding that the involvement of VEGF and TGF-β1 (transforming growth factor-beta1) aided angiogenesis. Accordingly, they observed a marked decrease in tumor necrosis factor-α (TNF-α) and increase in interleukin-10 (IL-10) in nanocompositetreated mice. Finally, the authors concluded the efficacy of nanocomposites in wound closing by regulating different cells in various phases of the healing procedure. Overall, copperbased nanomaterials demonstrated enormous potential for wound healing and might be clinically applied after detailed toxicity evaluation.\n(f ) Zinc oxide nanoparticles (ZnONPs)\nZinc is an essential trace element found in many enzymes as cofactors. Apart from its action in the central nervous system and immune response, zinc makes a major contribution to growth and development, and partakes in wound healing. Nanoform zinc, such as zinc oxide (ZnO) nanoparticles, have been reported to have applications in wound healing. The production of ROS, helpful for cell migration and adhesion, escalates the healing process by triggering growth factormediated pathways.112,113 For example, Augustine et al. conjugated polycaprolactone with ZnONPs using an electrospun technique to study its effects on wound healing in guinea pigs.113 The authors claimed that the as-prepared nanocomposite scaffold accelerated the wound healing process by enhancing ROS (especially H2O2) production up to an optimal level, which ameliorated fibroblast migration and proliferation. The in vivo wound healing efficacy of various implanted membrane groups (neat PCL membrane, ZnO nanoparticleincorporated PCL membrane, positive and negative control) on different days, starting from 0 to 30, is shown in Fig. 5. The authors also mentioned that the PCL membrane containing 1% ZnO displayed better wound healing properties with no sign of inflammation within the total time limit. Taken together, these ZnO NP-based composite scaffolds could be developed for future applications as skin substitutes in wound repair process. Recently, Yadav et al. investigated the wound curing potential of green synthesized Trianthema portulacastrum Linn. ZnO nanoparticles (ZnOTP).114 These nanoparticles were found to be permeable to the dermis and epidermis. The authors claimed that ZnOTP (2%) displayed remarkable wound healing abilities in vivo (rat model) through re-epithelialization, keratinocyte migration along with collagen fiber deposition, and tissue granulation. Furthermore, ZnOTP showed anti-inflammatory and anti-oxidant properties. Raguvaran et al. synthesized nanoconjugates containing ZnONPs and sodium alginate–gum acacia hydrogels (SAGA) to investigate the wound healing activity of the nanoconjugate.115\nThe authors suggested that incorporating ZnONPs into hydrogels allowed sustained release of ZnONPs at lower doses and also reduced the toxicity of ZnONPs. The group confirmed the antibacterial effect of this nanoformulation in different antibacterial susceptibility tests. Furthermore, the wound healing potential of this nanoconjugate was confirmed by increased fibroblast proliferation and migration rate at the scar area. Overall, zinc-based nanomaterials show great promise for wound healing applications and might prove to be a major game-changer in the near future.\n(g) Silica nanoparticles (SiNPs)\nAmong various metalloids, silica has received staggering attention in the field of wound healing. To produce more effective wound dressing materials, scientists have used silica, for example, in dressing materials and scaffold preparation. Quignard et al. reported the effect of silica nanoparticles on the proliferation and migration of human skin fibroblast cells (CCD-25SK), which is an important feature of wound repair.116 The authors suggested that silica nanoparticles (positively charged) were easily taken up by the fibroblast cells and dissolved intra-cellularly, releasing silicic acid and ultimately stimulating wound healing. This result indicated that silica nanoparticles could be used as a topical application for wound healing. Perumal et al. designed a wound dressing material using a collagen scaffold containing mupirocin (antibacterial) and silica microspheres.117 The authors concluded that the synergistic action of mupirocin, silica microspheres, and collagen caused a several-fold improvement in efficacy of the wound dressing material in Wistar Albino rats. The exudate adsorption efficacy of collagen increased the rehydration of necrotic tissue along with autocatalytic detriment of the wound. The authors mentioned that the silica microspheres maintained sustained release of drugs, such as mupirocin, into the wound and enhanced fibroblast proliferation in a manner that was anticipated to promote wound healing. Similarly, Alvarez et al. investigated the effectiveness of nanocomposite formulations using collagen type-1 hydrogel and silica nanoparticles as wound dressing materials.118 The authors loaded two antibiotics, gentamycin and rifamycin, into the hydrogels separately, by a simple process for antibiotic delivery. The authors confided that particle immobilization reduced the toxicity toward fibroblast cells and the harmonious effect of the two components escalated the proteolytic stability and mechanical properties of the hydrogel. This study encourages the future possible use of the composite materials in biological systems owing to their efficacy in preventing wound infection. Similarly, Öri et al. developed a formulation using both SiO2 nanoparticles and PVP (polyvinylpyrrolidon), which ultimately escalated the wound healing process.119 The authors reported that the nanocomposite accelerated the wound healing process as PVP acted as a drug delivery vehicle, which led the silica nanoparticles to embed on the wound area. Furthermore, the migration and re-epithelialization processes accelerated wound healing. These findings support the wound healing properties of silica-\nThis journal is © The Royal Society of Chemistry 2019 Biomater. Sci., 2019, 7, 2652–2674 | 2661\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\nbased nanomaterials and their future application for wound care.\n(h) Titanium dioxide nanoparticles (TiO2 NPs)\nThe broad-spectrum use of titanium in various fields influenced its application to wound healing, similar to several other inorganic metals. For example, Khalid et al. conjugated bacterial cellulose (BC) with TiO2 to form nanoconjugates for use as wound dressings.120 The authors mentioned that BC was biocompatible, porous, and had high water retention, making it appropriate for wound care products. The group showed that the effectiveness of BC as a wound dressing material increased when it was conjugated with TiO2 nanoparticles. These newly formed nanocomposites showed marked biocompatibility and antibacterial activity. H&E staining of the tissues of different treated groups (BC-TiO2, BC, positive, and negative) confirmed that the nanoformulation (BC-TiO2) exhibited enhanced wound healing activity in a burn wound model (in vivo) through re-epithelialization, fibroblast migration, and angiogenesis (Fig. 6). Similarly, Peng et al. prepared an artificial skin equivalent nanocomposite using TiO2 and chitosan.121 These artificial skin equivalents exhibited low density and good thickness properties, with average biodegradability and adequate water absorptivity. The authors claimed\nFig. 5 Wound healing activity of the membrane on the 1st day (a, f, k, and p), 5th day (b, g, l, and q), 10th day (c, h, m, and r), 20th day (d, I, n, and s), and 30th day (e, j, o, and t) of implantation. The first column (a–e) indicates neat PCL membranes, the second column (f–j) indicates PCL membrane incorporated with 1 wt% ZnO nanoparticles, the third column (k–o) indicates povidone–iodine-treated wounds (positive controls), and the fourth column (p–t) indicates negative controls. Reproduced from [90] R. Augustine, E. A. Dominic, I. Reju, B. Kaimal, N. Kalarikkal and S. Thomas, RSC Adv., 2014, 4, 24777–24785. Copyright © 2014 Royal Society of Chemistry.\n2662 | Biomater. Sci., 2019, 7, 2652–2674 This journal is © The Royal Society of Chemistry 2019\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\nthat the composite materials maintained a moderate TNF-α level, which indicated its anti-inflammatory effect. Furthermore, the nanocomposite materials demonstrated profound wound healing abilities with good bactericidal activity when applied to the wound area. Similarly, nanoparticle biosynthesis has surged in the field of nanomedicine because the synthetic processes are cost effective, environmentally friendly, and can be conducted at ambient temperature and neutral pH. Sankar et al. used Origanum vulgare plant extract to prepare TiO2 nanoparticles and studied their wound healing activity in Wistar male Albino rats.122 The authors claimed that nanoparticle treatment at the wound site accelerated wound healing by aiding collagen deposition, fibroblast formation, and macrophage accumulation at the wound site. Sivaranjani et al. synthesized TiO2 nanoparticles from Moringa oleifera leaves under optimum conditions.123 The nanoparticles were characterized, showing sizes of 100 nm. The researchers claimed that the nanoparticles exhibited enhanced wound healing activity in a wound excision model in albino rats. They also observed antimicrobial activity against both Gram-negative and Gram-positive bacteria. These findings are promising for the future, with TiO2 nanoparticles having potential applications in effective wound care products. However, detailed toxicity studies are required before their clinical application. (i) Super paramagnetic iron oxide nanoparticles (SPIONs) The unique physicochemical properties of super paramagnetic iron oxide nanoparticles (SPIONs), including their small size, MRI-contrast properties, ease of synthesis, and surface modification, negligible toxicity, and biodegradability, allow them to serve as excellent imaging contrast agents, diagnostic agents, and drug delivery vehicles for cancer theranostics applications.124,125 Recently, various groups have used SPIONs for wound healing and antimicrobial applications.126,127 Ziv-Polat et al. demonstrated the enhanced wound healing efficacy of thrombin (a topical wound healing agent) compared with free thrombin in incisional wounds on rat skin. As the half-life of thrombin in human plasma (∼15 s) is very short, the authors proposed to increase its half-life by conjugation with SPIONs.127 The results showed that SPION-conjugated thrombin showed higher skin tensile strength compared with free thrombin, which also correlated with the histological findings. In another recent report, Khasan et al. used iron oxide nanoparticle (INP)-decorated carbon nanotubes (CNTs) as antibacterial agents against various Gram negative and Gram positive bacteria. The authors also successfully demonstrated the wound-healing activity of the INP-CNT nanocomposite in animal models.128 These observations affirm the promising wound healing application of SPIONs. However, further research is\nFig. 6 H&E stained representative microphotographs of the treated wound tissue: (a) BC–TiO2, (b) BC, (c) positive control, and (d) negative control. The BC–TiO2 treated group showed signs of proper healing progression as fibroblasts, epithelial cells, and small blood vessels can be seen in the regenerated epithelium. Reproduced from ref. 97 A. Khalid, H. Ullah, M. Ul-Islam, R. Khan, S. Khan, F. Ahmad, T. Khan and F. Wahid, RSC Adv., 2017, 7, 47662–47668. Copyright © 2017 Royal Society of Chemistry.\nThis journal is © The Royal Society of Chemistry 2019 Biomater. Sci., 2019, 7, 2652–2674 | 2663\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\nneeded to support their wound healing ability and biocompatibility before their clinical translation.\n( j) Nonmetallic inorganic nanoparticles\nOnly a handful of reports have been published on the use of nonmetallic nanoparticles in wound healing applications. In a recent study by Viswanathan et al., iodine nanoparticles were synthesized by coprecipitation using polyvinyl pyrrolidone as a stabilizer upon reacting calcium lactate, disodium hydrogen phosphate, and iodine solution in the presence of sodium hydroxide as catalyst. These iodine nanoparticles showed significant inhibition of bacterial growth and biofilm formation at very low doses, and wound healing applications toward an in vivomouse model.129\nA list of inorganic nanoparticles used in wound healing studies is provided in Table 2."
    }, {
      "heading" : "11. Tissue regeneration using inorganic nanomaterials",
      "text" : "Tissue engineering uses a combination of materials, scaffolds, composites, cell lines, and effector compounds to mimic cellbased structures and organ behavior. Although autografts are the gold standard for tissue replacement processes, an alternative approach is urgently required due to several limitations, including potential organ rejection or tissue damage. Recently, several inorganic nanomaterials have been explored in fabricating tissue engineering scaffolds because they can overcome the limitation of the low number of cell adhesion sites observed for conventional polymer-based scaffolds.131,132 Furthermore, INPs have been explored for various diagnostic applications such as identifying markers in early detection of dreadful diseases such as cancer.133\nINPs demonstrate several advantages over growth factors in terms of increased stability, longer half-life, enhanced tissue retention and ease of immobilization for fabricating scaffolds, which greatly encourage their use for tissue repair and regeneration.131,134\n(a) Stem cell targeting\nStem cell transplantation has potential for the treatment of different tissue injuries. Nanoparticle-based stem cell targeting of tissue damage and neurodegenerative diseases is highly effective in overcoming challenges, such as low retention and engraftment of delivered stem cells at the damaged target site. Recently, several groups have used magnetic SPIONs for the labeling and delivery of stem cells to repair sites. Vandergrif et al. demonstrated the Ferumoxytol labeling of rat cardiosphere-derived stem cells (CDCs), and intra-coronarily infused these FDA-approved Ferumoxytol-labeled CDCs into rats with myocardial ischemia, which resulted in three-fold higher cardiac retention (Fig. 7).135 The authors performed T2-MRI imaging and fluorescence imaging to demonstrate cell retention 24 h after delivering Ferumoxytol-labeled CDCs into rats with myocardial infarction (Fig. 7).135 However, it is important to highlight that magnetic targeting did not result in increasing cardiac inflammation. Similar approaches have been followed by other groups, where iron oxide-labeled mesenchymal stem cells (MSCs) were used to target the cardiac site using magnetic power, resulting in cardiac retention in a rat model with myocardial infarction.136 In another published report, stem cells labeled with SPIONs were used to rapidly target lesions for spinal cord injury repair applications.137 These studies demonstrated a successful strategy for the focused targeting and fast delivery of stem cells using non-invasive magnetic nanoparticles that will aid rapid stem cell transplantation. Similar approaches\nTable 2 Comparison of inorganic nanoparticles used in wound healing\nTypes of nanoparticles Special characteristics Applications\nSilver nanoparticles Anti-bacterial, anti-inflammatory properties, useful for healed wounds; better clinical efficacy; effective at lower doses. Toxic at certain doses.\nBurn wounds;89 diabetic ulcers;90 anorectal surgery91\nGold nanoparticles Functionalized with antibiotics, peptide, and collagen scaffolds. High tissue adhesive properties; better anti-bacterial activity\nDiabetic wounds;130 Skin wound on rat model;100 rodent wound model101\nGraphene oxide nanoparticles\nEmbedded in scaffolds; anti-bacterial; faster re-epithelialization and shrinkage properties\nAs wound dressing in rats104 and murine model105; in tissue engineering a scaffold106.\nTerbium nanoparticles\nHelps in migration, proliferation, increases viability, assist in angiogenesis.\nMurine model,32 Zebrafish model (embryonic primary cells)107\nCopper nanoparticles\nAnti-microbial activity, enhanced wound healing by producing different growth factors; fabricated in dressing materials\nExcision model in rat;109 murine model;111 in wound dressing110\nZinc oxide nanoparticles\nIncorporated in hydrogels; anti-inflammatory, anti-oxidant properties; enhances angiogenesis, ROS production\nOn guinea pigs;113 skin wound on rat model;114 in vitro conditions115\nSilica nanoparticles Easy fabrication and loading of drugs; helps in migration and proliferation of fibroblast.\nTopical applications;116 wound dressing in rat model (Wistar rat);117 murine model119\nTitanium nanoparticles\nBiocompatible, bio-synthesized, inherent bioactivity, enhanced wound healing ability, water retaining efficacy\nBurn wound model;120 rat mode (Wistar rat);122 albino rats123\nIron oxide nanoparticles\nEasy synthesis, biodegradability, low toxicity, anti-microbial applications\nIncisional wound in Wistar rat;127 murine model128\n2664 | Biomater. Sci., 2019, 7, 2652–2674 This journal is © The Royal Society of Chemistry 2019\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\nhave been taken by Chen et al., who utilized pegylated magnetite NPs coated with anti-CD34 antibody to facilitate stem cell targeting that helped the NPs to bind with blood stem cells and target delivery at lesions in the presence of a magnetic field.138\n(b) Neuroregeneration and nerve repair\nNeurodegenerative disease, neurotrauma, and spinal cord injury are rapidly growing diseases that affect a vast population, with several cases remaining incurable due to the lack of a proper treatment.139 Graphene and carbon nanotubes (CNTs) demonstrate promising applications in neural repair owing to their high mechanical strength and excellent electrical conductivity. In an exciting recent study, Kim et al. demonstrated that PEGylated graphene nanoribbons (PEG-GNR) could help recover the locomotor function in a rat model with lumbar spinal cord transection. TexasPEG is a mixture in which graphene is diluted by 600 Da of PEG. TexasPEG treatment eased glial scar formation without imposing gross damage and helped profuse axonal growth in the periphery of the spinal lesion.140 In a different study, reduced graphene oxide (rGO) scaffolds were implanted into the spinal\nFig. 7 Magnetic targeting boosts the retention of ferumoxytol-labeled CDCs in rats with ischemia/reperfusion. A: FHP-labeled rat CDCs. B: Serum TnI values measured by ELISA 24 h after intracoronary injection of 500 000 cells into naïve (non-infarcted) rats. C: T2* weighted MRI images showing cell retention 24 h after delivery of CDCs into rats after myocardial infarction. The presence of iron created a signal void (dark area; pointed with red arrows). D: Fluorescent imaging showing the presence of RFP-labeled CDCs (red) in hearts and lungs. E: SRY qPCR quantitation of cell retention. All experiments were performed in triplicate. Reproduced from ref. 105 A. C. Vandergriff, T. M. Hensley, E. T. Henry, D. L. Shen, S. Anthony, J. Y. Zhang and K. Cheng, Biomaterials, 2014, 35, 8528–8539. Copyright © 2014 Elsevier.\nThis journal is © The Royal Society of Chemistry 2019 Biomater. Sci., 2019, 7, 2652–2674 | 2665\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\ncords of injured rats to understand and determine the effects of rGO on inflammatory, fibrotic, and angiogenic changes over 30 days of study at the tissue site (Fig. 8).141 The rGO scaffolds supported angiogenesis, as observed by the growth of blood vessels and red blood cells at the tissue/scaffold interface 30 days postimplantation. Importantly, regenerated neuronal axons were observed inside the scaffolds, along with new blood vessels. In contrast, no blood vessels and axons were observed without rGO scaffolds, which further supported the significance of rGO in the treatment of spinal cord injury (Fig. 8).\nRecently, inorganic nanomaterials were also used for neuronal cell restoration and neuroprotection applications. A recent report by Baranes et al. demonstrated improved functional and structural neuroregeneration, neuronal differentiation, and maturation using a gold nanoparticle-decorated scaffold.142 Furthermore, AuNPs decorated on polycaprolactone (PCL)/ gelatin scaffolds were stable and biocompatible for long periods in vivo. The AuNP-decorated implants created neuronal networks and reached adjacent cells, whereas the neurons on the regular scaffolds did not elongate long neuritis. However, further studies are needed to understand the role of axon elongation and higher neuronal marker expression resulting from the conductivity of the gold-decorated scaffolds.\n(c) Cardiac repair\nCardiac diseases are among the major causes of mortality, morbidity, and disability globally, thereby responsible for about 17.9 million deaths worldwide anually.143 Direct and indirect costs of cardiac diseases are estimated to ∼US$329.7 billion in the USA.144 Conventional treatment strategies, including cytokines and drugs, have several limitations, including fibrosis, tumorogenesis, thrombosis, and non-specificity. Inorganic nanoparticles were recently used for cardiac regeneration and repair applications to help increase cell adhesion sites and electrical conductivity. Alginate–gold nanowire scaffolds were used to boost the electrical conductivity of the nanocomposite and assist electrical signaling.145 Tissue and cells grown on the surface of these nanocomposite scaffolds were thicker, better synchronized, had higher electrical properties, and showed improved alignment compared with cells and tissue grown on pristine alginate. Ahadian et al. recently used CNT-incorporated hybrid methacrylated gelatin hydrogels scaffolds to culture and regulate the cardiac differentiation of mouse embryoid bodies.146 Graphene oxide (GO) and reduced graphene oxide (rGO) have shown interesting concentration-dependent pro-angiogenic and anti-angiogenic properties that can be used for cardiac repair through angiogenesis.147 GO scaffolds and thin films were used as cell adhesive to generate multilayer connected tissue, resulting in better cardiomyocyte cell organization, powerful spontaneous beating, and cell-to-cell electric coupling.148 Recently, our group demonstrated the potential of pro-angiogenic europium hydroxide nanorods (EHNs) to overcome myocardial ischemia induced by isoproterenol in Wistar rats.149 Similarly other reports demonstrated preparation of hydrogels encapsulating functionalized\nFig. 8 Histological examination of the interface and lesion sites 30 days post-injury using HvG staining. Panoramic (top, scale bars: 1 mm) and zoom-in (bottom, scale bars: 100 μm) optical microscopy images are displayed. Spinal cords are oriented in all cases as indicated by the set of arrows: Ro, Rostral; C, Caudal; D, Dorsal; and V, Ventral. Reproduced from ref. 111 E. Lopez-Dolado, A. Gonzalez-Mayorga, M. C. Gutierrez and M. C. Serrano, Biomaterials, 2016, 99, 72–81. Copyright © 2016 Elsevier.\n2666 | Biomater. Sci., 2019, 7, 2652–2674 This journal is © The Royal Society of Chemistry 2019\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\ngraphene oxide (fGO) nanocomplex and VEGF carrying gene and therapeutic evaluation in a rat model of myocardial infarction. Intra-myocardial injection of these hydrogels in rats showed increased myocardial capillary density and reduced scar area with significantly higher cardiac performance.150"
    }, {
      "heading" : "12. Mechanism of wound healing by inorganic nanoparticles",
      "text" : "The wound healing process is complex and can be affected by various potential factors, including microbes. The effects of bacteria on wound healing are of great interest, as chronic wounds are mostly associated with bacterial colonies delaying the healing process. Several Gram positive and Gram negative bacteria are known to cause wound infections and significantly alter wound closure.151 The main mechanisms underlying bacterial infections are known to cause a prolonged increase in proinflammatory cytokines,152 elevated levels of matrix metalloproteases, and decreased growth factor release.153 Conventionally, antibiotics have been preferred to address bacterial infections. However, this approach has been limited by the development of multidrug-resistant bacterial strains, costineffectiveness, and systemic toxicity.154 Nanoparticles have emerged as excellent antibacterial agents with immense potential for wound healing applications.158–163 For decades, AgNPs have been widely evaluated for wound healing owing to their potent antibacterial properties.90 Several groups have extensively reported the mechanism of antibacterial activity of AgNPs. AgNPs have been reported to penetrate the bacterial cell wall and interact with sulfur and phosphorous-rich amino acids and nucleic acids.155 Silver ions released from the NPs damage the cell wall and all cellular components, leading to apoptosis and bactericidal activity.78 Thereby, AgNPs protect wounds from microbial infections and aid efficient wound closure without causing further complications. Furthermore, other noble metal NPs, such as AuNPs, have been shown to enhance wound healing by exhibiting anti-bacterial activity. AuNPs are reported to deplete cellular adenosine triphosphate (ATP) levels by altering the membrane potential and inhibiting enzyme ATP synthase, eventually leading to hampered energy metabolism and bacterial death.156 AuNPs are also known to exhibit bactericidal activity in a ROS-independent manner in\nmultiple-drug resistant bacteria. A list of inorganic nanoparticles that exhibit anti-bacterial activity is provided in Table 3.\nInterestingly, another set of nanoparticles promote wound healing by triggering the optimum intracellular ROS and inducing angiogenesis. Zn transition metal nanomaterials have been widely incorporated as metal oxides in polymeric scaffolds for wound healing applications.164 Our group has previously reported that ZnO stimulates ROS formation in endothelial cells, which acts downstream in a p38MAPK/Akt/ eNOS-dependent fashion to stimulate angiogenesis.165 Augustine et al. showed that upregulation of key angiogenesis growth factors, including vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF), plays a crucial role in the ZnO NP-induced proangiogenesis.166 Therefore, ZnO NPs plausibly accelerate the wound healing process through the angiogenesis pathway. Lanthanide nanomaterials, such as terbium hydroxide nanoparticles (THNs), accelerate wound healing through a ROS/NO signaling axis.32 THNs trigger ROS in a NOX-dependent manner, which activates eNOS in a PI3K/Akt/MAPK-signaling manner, leading to the formation of NO, which is well-known to induce angiogenesis and promote wound healing (Fig. 9).32,167 Therefore, understanding the molecular mechanisms and regulatory pathways underlying the INP-mediated wound healing process is essential for developing these nanocandidates as alternative clinical approaches for wound treatment."
    }, {
      "heading" : "13. Advantages and disadvantages of inorganic nanoparticle-based wound healing",
      "text" : "INPs have seen dramatic advances in biology and medicine, such as in drug delivery for cancer therapy and biomedical imaging. INPs are well known for their effectiveness, versatility, ease of functionalization, non-invasiveness, and lowimmunogenicity.168 Recently, these INPs have been rigorously investigated for their use in tissue repair and regeneration, with a special focus on accelerating wound healing. Numerous INPs, such as AuNPs, AgNPs, ZnO NPs, and THNs, have been explored by scientists against in vitro mammalian\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\ncells and in vivo mouse models for their ability to promote wound closure. INPs have several advantages, such as ease of production, biocompatibility, low toxicity, scalability, and high bioavailability.169 Chronic wounds are generally characterized by infection caused by bacterial growth and bacterial bio-films, which create protection by producing an extracellular polymeric substance.170 Such biofilm-associated wounds exhibit inhibited re-epithelialization, prolonged inflammation, and high resistance to conventional therapies.171,172 INPs such as AgNPs have effective advantages against biofilm-forming bacteria and multi-resistant strains.173,174 Commercially available silver-based formulations are extensively used to address chronic and burn wounds, and infections. However, the application of these conventional formulations is limited owing to toxicity concerns. AgNPs synthesized with a high-surface-to-volume ratio demonstrate effective wound healing properties with reduced toxicity. However, issues such as long-term tissue deposition and degradation of the INPs alert their application for human use. Without a proper understanding of the long-term fate of nanoparticles in biological systems, their clinical translation becomes critical. Conventional wound healing therapy-based creams or ointments show good stability, while the preparation of stable nanomedicine-based formulations with a longer shelf life remains challenging. Despite rigorous investigations into nanomaterial applications to wound healing, the detailed mechanism involved in their activity has yet to be clearly understood. Understanding the impact of nanomaterials with special emphasis on different phases of wound healing is essential to enhance their therapeutic potential and reduce the doselimited toxicity."
    }, {
      "heading" : "14. Clinical status of inorganic nanomedicine in wound healing",
      "text" : "Wound healing is a complicated process and has long been a matter for discussion. The recent advent of nanotechnology in the wound healing domain has given modality to the overall process. With the increased number of nanotherapies that have emerged for wound healing, inorganic nanomedicines are of paramount importance among them. Four therapies have received FDA approval for the treatment of cutaneous wounds, namely, human skin equivalent, two types of dermal substituent, and a human platelet-derived growth factor (recombinant).175–177 The human skin equivalent and dermal substituents act as smart biomedicines when applied to the wound area. In contrast, the human platelet derived growth factor (rhPDGF) therapy is advantageous because it aids the continuous flow of various cells to the wound area. PDGF exerts favorable effects on wound healing by stimulating the neutrophils, macrophages, and fibroblasts, among others. However, 44–70% of people suffering from chronic ulcers still remain unhealed after PDGF therapy. Meanwhile, modern dressing materials that\nFig. 9 Overall schematic representation of the molecular signaling cascade governing the pro-angiogenic and wound healing properties of THNRs. Reproduced from ref. 32 S. K. Nethi, A. K. Barui, V. S. Bollu, B. R. Rao and C. R. Patra, ACS Biomater. Sci. Eng., 2017, 3, 3635–3645. Copyright © 2017 American Chemical Society.\n2668 | Biomater. Sci., 2019, 7, 2652–2674 This journal is © The Royal Society of Chemistry 2019\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM .\nare beneficial for wound healing have entered the market. These active dressing materials improve the wound environment. Despite several efforts and the use of improved dressing materials, many of the modalities applied clinically rely on safety data and experience rather than the efficacy rate.18,178,179 We have listed some of the inorganic basednanomedicines that are under clinical investigation in Table 4."
    }, {
      "heading" : "15. Challenges, future directions, and conclusions",
      "text" : "Although more than 6.5 million people in the USA are affected by various types of wound annually, recent research has had limited success, affording only a handful of FDA-approved therapeutic agents due to (a) the complexity of the tissue repair process, (b) understanding of the pathophysiology, (c) a lack of awareness, (d) inconsistency in the patient population for available therapeutic strategies, (e) difficulties in treating diabetic wounds, and (f) the complexity of proper clinical design. These pitfalls clearly underline the need for advances in current strategies using alternative approaches, such as nanomedicine. Recently, inorganic nanomaterials have shown great promise for treating various wounds and achieving tissue repair. Furthermore, these nanomaterials can play important roles in tissue adhesion, stem cell targeting, drug delivery, and differentiation. The future of INPs is bright owing to the synergy between physicochemical (magnetic, optical, and electronic) and biological (anti-microbial and angiogenesis) properties that trigger the successful design of alternative wound healing agents. Although several nanoparticles have been explored, scientists are still probing new approaches to implementing nanotechnology in wound healing treatments. Researchers at Ohio State University have recently developed a method called Tissue Nanotransfection (TNT) that reprograms\ntissues in the body using a nanochanneled chip to aid the healing process.189 Furthermore, the delivery of drugs and nucleic acids helps to expedite the wound healing process. However, there are still some lacuna to be filled, including the long term safety of nanomaterials,190–192 the bulk scale synthesis of high purity nanomaterials as per FDA standards, the development of appropriate combinational therapies, understanding of the role of nanostructural properties in effective tissue repair and wound healing, discoloration of skin upon long term exposure, and the reoccurrence of NP-resistant bacteria. Therefore, comprehensive studies are required to understand the in-depth molecular mechanisms involved in wound healing and formulate effective strategies to translate INPs for effective wound care and management. Finally, as several INPs have already entered clinical use for various biomedical applications, including cancer therapy, imaging, sensing, drug delivery, and anti-bacterial applications, the pathway for the clinical translation of these inorganic nanomaterials for wound healing, and tissue repair and regeneration is anticipated to be rationalized soon.\nConflicts of interest\nThe authors declare no conflicts of interest."
    }, {
      "heading" : "Acknowledgements",
      "text" : "CRP is grateful to CSIR, New Delhi for CSIR-Mayo Clinic Collaboration for Innovation and Translational Research (CKM/ CMPP-09; MLP0020) and DST-Nanomission, New Delhi (SR/ NM/NS-1252/2013; GAP 570) for financial support. SD is thankful to UGC for Senior Research Fellowship. IICT Manuscript Communication Number: IICT/Pubs./2019/096 (dated March 12, 2019) is duly acknowledged. SM is thankful to Dr Omid Veiseh (postdoctoral mentor) for his continuous support.\nTable 4 Metal (inorganic) based nanomedicine under clinical investigations\nInorganic NPs Specific features Animal model\nGold It can be functionalized using various antibiotics, antioxidants; can be utilized in gene therapy\nMurine model (diabetic)130\nSilver Anti-microbial activity; as wound dressing Diabetic ulcers along for the treatment of burn wounds and leg ulcers;180,181 human burn wounds;89,182,183 type II and type III burn injuries;184 military wounds;185 anorectal surgery;91 chronic diabetic foot ulcers in human;186 wister albino rats187\nCopper Accelerated wound healing through angiogenesis, fibrinogen formation and collagen deposition\nRat model (excision)109,110\nCerium oxide Enhanced wound healing; act as antioxidant Cutaneous wounds, full thickness wounds in murine model31\nTitanium oxide Anti-bacterial, anti-inflammatory, biocompatible in nature; biosynthesized\nRat model; burn wound120,121,123\nZinc oxide Production of ROS, helping in migration, proliferation of endothelial cells\nGuinea pigs;113 rat model;114 dermal area; burn wound in rabbit model188\nSilica Intracellular dissolution followed by releasing of silicic acid; anti-microbial activity\nRat model116,118\nThis journal is © The Royal Society of Chemistry 2019 Biomater. Sci., 2019, 7, 2652–2674 | 2669\nPu bl\nis he\nd on\n2 4\nA pr\nil 20\n19 . D\now nl\noa de\nd by\nK E\nA N\nU N\nIV E\nR SI\nT Y\no n\n7/ 31\n/2 01\n9 4:\n32 :0\n7 A\nM ."
    } ],
    "references" : [ {
      "title" : "American Heart Association Statistics and S",
      "author" : [ "J. Stein", "A. Towfighi", "T.N. Turan", "S.S. Virani", "D. Woo", "R.W. Yeh", "C.M.B. Turner" ],
      "venue" : "Stroke Statistics, Circulation,",
      "citeRegEx" : "Stein et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Stein et al\\.",
      "year" : 2016
    } ],
    "referenceMentions" : [ ],
    "year" : 2019,
    "abstractText" : "Chronic wounds have emerged as a major cause of mortality, especially in patients with diabetes and other pathologies. Statistics indicate that chronic wounds affect around 6.5 million patients annually, with wound care and management incurring huge economic costs. Growing incidence of chronic wounds and associated pathologies along with the limitations of current therapies have established a strong need for novel and innovative approaches to accelerate wound healing. Conventionally, chronic wounds are addressed using various FDA-approved silver-based formulations and other biomaterials. However, the toxicity associated with these conventional approaches, along with the increased frequency of chronic wound cases, makes the development of alternative therapies for effective wound healing necessary. Recently, researchers have investigated the design and development of nanoparticles, especially inorganic metal nanoparticles, as promising candidates for addressing various pathological conditions, including wound healing. Several research groups, including ours, have designed numerous metal nanoparticles (including silver, gold, zinc oxide, cerium oxide, terbium hydroxide, silica, titanium oxide, copper) and demonstrated their wound-healing properties using in vitro and in vivo models. The rise of nanotechnology-based platforms in wound healing is evidenced by the tremendous impact and number of publications observed in recent years, which has emphasized the robust potential of inorganic nanomedicine for addressing wounds. Therefore, the importance of these inorganic nanomaterial-based interventions for wound-healing applications needs to be emphasized to inform and encourage scientists and young researchers globally to engage with this expanding area of biology and medicine. In this review article, we mainly focus on highlighting the role of inorganic nanomaterials and nanomaterial-based approaches for wound healing and tissue regeneration, along with their mechanistic properties, clinical status, challenges, and future directions.",
    "creator" : "Arbortext Advanced Print Publisher 9.1.520/W Unicode"
  }
}